![Ivan Griffin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Griffin
Fondateur chez
BENEVOLENTAI S.A.
Profil
Ivan Griffin was the founder of BenevolentAI Ltd., founded in 2015, where the title held was Senior Vice President-Partnerships.
Dr. Griffin is the founder of BenevolentAI SA, founded in 2013, holding the title of Chief Business Officer.
Dr. Griffin is currently Director at BenevolentAI Cambridge Ltd. since 2019.
Former jobs include Secretary & Director at Cerogenix Ltd. from 2005 to 2007, Director at Sirigen Group Ltd., Principal at IP Group Plc, and Investment Manager at Nesta Investment Management LLP from 2009 to 2014.
Education includes undergraduate and doctorate degrees from the University of Oxford.
Postes actifs de Ivan Griffin
| Sociétés | Poste | Début |
|---|---|---|
| BENEVOLENTAI S.A. | Fondateur | 01/11/2013 |
BenevolentAI Cambridge Ltd.
 BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to pharmaceutical companies in the areas of Parkinsons disease and other neurodegenerative disorders | Directeur/Membre du Conseil | 29/05/2019 |
Anciens postes connus de Ivan Griffin
| Sociétés | Poste | Fin |
|---|---|---|
Nesta Investment Management LLP
 Nesta Investment Management LLP Investment ManagersFinance Nesta Investments invests in companies located in the United Kingdom. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements with an investment size ranging from GBP 0.15 to 2 million and also makes follow-on investments. | Private Equity Investor | 01/01/2014 |
Cerogenix Ltd.
 Cerogenix Ltd. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research and development services | Directeur/Membre du Conseil | 24/08/2007 |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Fondateur | - |
Sirigen Group Ltd.
 Sirigen Group Ltd. Chemicals: Major DiversifiedProcess Industries Develops polymer dyes used in flow cytometry | Directeur/Membre du Conseil | - |
| IP GROUP PLC | Corporate Officer/Principal | - |
Formation de Ivan Griffin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IP Group Plc
 IP Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property commercialization and venture capital fund management company | Commercial Services |
BenevolentAI Cambridge Ltd.
BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to pharmaceutical companies in the areas of Parkinsons disease and other neurodegenerative disorders | Commercial Services |
Cerogenix Ltd.
Cerogenix Ltd. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research and development services | Commercial Services |
Sirigen Group Ltd.
Sirigen Group Ltd. Chemicals: Major DiversifiedProcess Industries Develops polymer dyes used in flow cytometry | Process Industries |
Nesta Investment Management LLP
Nesta Investment Management LLP Investment ManagersFinance Nesta Investments invests in companies located in the United Kingdom. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements with an investment size ranging from GBP 0.15 to 2 million and also makes follow-on investments. | Finance |
BenevolentAI Ltd.
BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Technology Services |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
Choisissez Zonebourse 
